In the United States alone, there are currently approximately 14.5 million cancer survivors,
and this number is expected to increase to 20 million by 2020. Cancer therapies can cause …

Cardiologists are encountering a growing number of cancer patients with ischaemic heart
disease (IHD). Several factors account for the interrelationship between these two …

Objective: The aim of this study was to analyze the early and long-term results of
simultaneous surgical treatment of both coronary heart disease (CHD) and lung cancer …

A best evidence topic in cardiac surgery was written according to a structured protocol. The
question addressed was whether combined surgical procedures in one or two stages are …

Owing to early diagnosis and rapid development of treatments for cancers, the five-year
survival rate of all cancer types has markedly improved worldwide. Over time, however …

Candidate patients for cardiac surgery procedures with a history of malignancies and
antitumour therapy or with an active cancer and on antineoplastic treatment are increasingly …

Adverse effects of cardiopulmonary bypass on cancer prognosis are expected but have not
been confirmed. Seventy-four cancer patients who underwent cardiac surgery before cancer …

Background The surgical strategy among patients with malignancy and coronary artery
disease (CAD) remains controversial. In this study, we present the experiences of coronary …

This study was designed as an external evaluation of the Steyerberg score in the prediction
of different categories of postoperative mortality after esophagectomy on a large nationwide …

Background To investigate the possibility and feasibility of simultaneous cardiac and
noncardiac surgery. Methods From August 2000 to March 2015, 64 patients suffering from …